Effects of vessel geometric irregularity on dissolution test results

Journal of Pharmaceutical Sciences

Volumn 100, Issue 3, 2011, Pages 1093-1101

  Gao, Zongming ^a   Ahadi, Shafiq ^a   Moore, Terry W ^a   Doub, William H ^a   Westenberger, B J ^a   Buhse, Lucinda F ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

Analysis; Apparatus 2; Dissolution; Geometric irregularity; In vitro method; Physical characterization; Solid dosage form; VMM

Indexed keywords

PREDNISONE;

ARTICLE; CALIBRATION; DRUG SOLUBILITY; GEOMETRY; IN VITRO STUDY;

EID: 79251588049     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.22319     Document Type: Article

References (19)

1. Dressman J, Kramer J. 2005. Pharmaceutical dissolution testing. Boca Raton: Taylor & Francis.
2. Cox DC, Furman WB. 1984. Collaborative study of the USP dissolution test for prednisone tablets with apparatus 2. J Pharm Sci 73(5):670-676.
3. Layloff T. 1983. Studies in the development of USP dissolution test method number 2. Pharmacopeial Forum, 9: 3752-3757.
4. Shah VP, Lesko LJ, Fan J, Fleischer N, Handerson J, Malinowshi H, Makary M, Ouderkirk L, Ruy S, Sathe P, Singh GJ, Tillman L, Tsong Y, Williams RL. 1997. FDA guidance for industry dissolution testing of immediate release solid oral dosage forms. Dissol Technol 11:15-22.
5. Dokoumetzidis A, Macheras P. 2006. A century of dissolution research: From Noyes and Whitney to the Biopharmaceutics Classification System. Int J Pharm 321:1-11.
6. The CGMP guidance on use of mechanical calibration of dissolution apparatus 1 and 2. Accessed June 2, 2010, at.
7. Siewert M, Weinandy L, Whiteman D, Judkins C. 2002. Typical variability and evaluation of sources of variability in drug dissolution testing. Eur J Pharm Sci 53:9-14.
8. Gao Z, Moore TW, Doub WH, Westenberger BJ, Buhse LF. 2006. Effects of deaeration methods on dissolution testing in aqueous media: A study using a total dissolved gas pressure meter. J Pharm Sci 95(7):1606-1613.
9. Gao Z, Moore T, Smith AP, Doub W, Westenberger B, Buhse L. 2007. Gauge repeatability and reproducibility for accessing variability during dissolution testing: A technical note. AAPS Pharm Sci Tech 8(4):11-15.
10. Qureshi SA, Shabnam J. 2001. Cause of high variability in drug dissolution testing and its impact on setting tolerances. Eur J Pharm Sci 12:271-276.
11. Gao Z, Moore TW, Doub WH. 2008. Vibration effects on dissolution tests with USP apparatuses 1 and 2. J Pharm Sci 97:3335-3343.
12. United States Pharmacopeia. USP 32. 2009. Physical tests, <711> dissolution, 264. Rockville, MD, United States Pharmacopeia.
13. Cox DC, Wells CE, Furman WB, Savage TS, King AC. 1982. Systematic error associated with apparatus 2 of the USP dissolution test II: Effects of deviations in vessel curvature from that of a shape. J Pharm Sci 71(4):395-399.
14. Scott P, Irregularities G. 2005. Common to the dissolution vessel. Dissol Technol 2:18-21
15. Tanaka M, Fujiwara H, Fujiwara M. 2005. Effect of the irregular inner shape of a glass vessel on prednisone dissolution results. Dissol Technol 11:15-19.
16. Liddell MR, Deng G, Hauck WW, Brown WE, Wahab SZ, Manning RG. 2007. Evaluation of glass dissolution vessel dimensions and irregularities. Dissol Technol 1:28-33
17. Liddell MR, Deng G, Hauck WW. 2007. Dissolution testing variability: Effect of using vessels from different commercial sources. Am Pharm Rev V10(6):122-128
18. Foster LW. 1986. Introduction to geometric dimensioning and tolerancing. Fort Washington, MD: National Tooling and Machining Association.
19. ASTM International. 2007. ASTM method E2503-07: Standard, practice for qualification of basket and paddle dissolution apparatus. West Conshohocken, PA: ASTM International.